Eosinophil Granule Proteins: Form and Function
暂无分享,去创建一个
[1] Paige Lacy,et al. Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice , 2014, Allergy.
[2] S. Ackerman,et al. To be, or not to be, an eosinophil: that is the ??? , 2013, Blood.
[3] James J. Lee,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Expression of the secondary granule proteins major basic protein 1 ( MBP-1 ) and eosinophil peroxidase ( EPX ) is required for eosinophilopoiesis in mice , 2013 .
[4] Marc Torrent,et al. Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7 , 2013, Antimicrobial Agents and Chemotherapy.
[5] H. Simon,et al. Extracellular DNA traps in allergic, infectious, and autoimmune diseases , 2013, Allergy.
[6] K. Dyer,et al. Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.
[7] H. Simon,et al. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. , 2012, Current opinion in immunology.
[8] Ulla-Britt Jönsson,et al. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. , 2012, World journal of gastroenterology.
[9] M. V. Nogués,et al. Exploring New Biological Functions of Amyloids: Bacteria Cell Agglutination Mediated by Host Protein Aggregation , 2012, PLoS pathogens.
[10] H. Simon,et al. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps , 2012, Allergy.
[11] D. Fleischer,et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis , 2012, Gut.
[12] J. Douglass,et al. Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation , 2012, PloS one.
[13] M. V. Nogués,et al. Structural determinants of the eosinophil cationic protein antimicrobial activity , 2012, Biological chemistry.
[14] A. Neunkirchner,et al. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] James J. Lee,et al. Eosinophils Preserve Parasitic Nematode Larvae by Regulating Local Immunity , 2012, The Journal of Immunology.
[16] E. Boix,et al. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization. , 2011, Journal of medicinal chemistry.
[17] H. Simon,et al. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. , 2011, The Journal of allergy and clinical immunology.
[18] E. Boix,et al. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage. , 2011, Biochimie.
[19] H. Simon,et al. Eosinophil extracellular DNA traps in skin diseases. , 2011, The Journal of allergy and clinical immunology.
[20] C. Janson,et al. Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study , 2010, BMC pulmonary medicine.
[21] C. Halldén,et al. CLC– a novel susceptibility gene for allergic rhinitis? , 2010, Allergy.
[22] Parameswaran Nair,et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.
[23] A. Engström,et al. The Coding ECP 434(G>C) Gene Polymorphism Determines the Cytotoxicity of ECP but Has Minor Effects on Fibroblast-Mediated Gel Contraction and No Effect on RNase Activity1 , 2009, The Journal of Immunology.
[24] James J. Lee,et al. Eosinophil Deficiency Compromises Parasite Survival in Chronic Nematode Infection1 , 2009, The Journal of Immunology.
[25] P. Venge,et al. Eosinophil Cationic Protein (ECP) Is Processed during Secretion , 2009 .
[26] M. Schirle,et al. Post-translational Tyrosine Nitration of Eosinophil Granule Toxins Mediated by Eosinophil Peroxidase* , 2008, Journal of Biological Chemistry.
[27] A. Straumann,et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.
[28] James J. Lee,et al. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. , 2008, Human molecular genetics.
[29] S. Phipps,et al. Eosinophils: Biological Properties and Role in Health and Disease , 2008, Clinical and Experimental Allergy.
[30] J. Parkin,et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. , 2008, The New England journal of medicine.
[31] H. Rosenberg,et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responses , 2008, The Journal of experimental medicine.
[32] P. Venge,et al. The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection. , 2007, International journal for parasitology.
[33] Christian Becker,et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. , 2007, Blood.
[34] A. Engström,et al. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post‐translational modifications , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[35] Shawn A. Mahmud,et al. Thiocyanate-Dependent Induction of Endothelial Cell Adhesion Molecule Expression by Phagocyte Peroxidases: A Novel HOSCN-Specific Oxidant Mechanism to Amplify Inflammation1 , 2006, The Journal of Immunology.
[36] G. Gleich,et al. Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells1 , 2006, The Journal of Immunology.
[37] M. Saeftel,et al. Lack of Eosinophil Peroxidase or Major Basic Protein Impairs Defense against Murine Filarial Infection , 2006, Infection and Immunity.
[38] C. J. Barnes,et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. , 2006, Immunity.
[39] C Tagesson,et al. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. , 2006, Journal of proteome research.
[40] J. Geng,et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. , 2006, Blood.
[41] G. J. Swaminathan,et al. Eosinophil-granule major basic protein, a C-type lectin, binds heparin. , 2005, Biochemistry.
[42] C. Wennerås,et al. Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. , 2005, Microbes and infection.
[43] S. Kingsmore,et al. Human Ribonuclease A Superfamily Members, Eosinophil-Derived Neurotoxin and Pancreatic Ribonuclease, Induce Dendritic Cell Maturation and Activation1 , 2004, The Journal of Immunology.
[44] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[45] E. Lenkiewicz,et al. Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.
[46] F. Levi-Schaffer,et al. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. , 2004, The Journal of allergy and clinical immunology.
[47] Paige Lacy,et al. Divergence of Mechanisms Regulating Respiratory Burst in Blood and Sputum Eosinophils and Neutrophils from Atopic Subjects1 , 2003, The Journal of Immunology.
[48] H. R. Evans,et al. The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. , 2002, Biochemistry.
[49] Wei Xu,et al. Immobilized Lactoferrin Is a Stimulus for Eosinophil Activation1 , 2002, The Journal of Immunology.
[50] Ulla-Britt Jönsson,et al. Polymorphism of the eosinophil cationic protein‐gene is related to the expression of allergic symptoms , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[51] G. J. Swaminathan,et al. Charcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion* , 2002, The Journal of Biological Chemistry.
[52] H. Rosenberg,et al. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens , 2001, Journal of leukocyte biology.
[53] S. Hazen,et al. Extensive Eosinophil Degranulation and Peroxidase-Mediated Oxidation of Airway Proteins Do Not Occur in a Mouse Ovalbumin-Challenge Model of Pulmonary Inflammation1 , 2001, The Journal of Immunology.
[54] G. J. Swaminathan,et al. Crystal Structure of the Eosinophil Major Basic Protein at 1.8 Å , 2001, Journal of Biological Chemistry.
[55] E. Boix,et al. Identification and characterization of human eosinophil cationic protein by an epitope‐specific antibody , 2001, Journal of leukocyte biology.
[56] G. J. Swaminathan,et al. Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN) , 2001, The Journal of Biological Chemistry.
[57] S.,et al. Biochemical Characterization of Human Eosinophil Charcot-Leyden Crystal Protein ( Lysophospholipase ) * , 2001 .
[58] James J. Lee,et al. Eosinophil Major Basic Protein-1 Does Not Contribute to Allergen-Induced Airway Pathologies in Mouse Models of Asthma1 , 2000, The Journal of Immunology.
[59] Jianzhi Zhang,et al. Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] E. Boix,et al. Crystal structure of eosinophil cationic protein at 2.4 A resolution. , 1999, Biochemistry.
[61] A. Fryer,et al. Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein. , 1999, Journal of applied physiology.
[62] Acharya,et al. Selective Recognition of Mannose by the Human Eosinophil Charcot-Leyden Crystal Protein (Galectin-10): A Crystallographic Study at 1.8 Å Resolution. , 1999, Biochemistry.
[63] E. Boix,et al. Kinetic and Product Distribution Analysis of Human Eosinophil Cationic Protein Indicates a Subsite Arrangement That Favors Exonuclease-type Activity* , 1999, The Journal of Biological Chemistry.
[64] Stephen Naylor,et al. A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein* , 1999, The Journal of Biological Chemistry.
[65] K. Dyer,et al. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. , 1998, Nucleic acids research.
[66] H. Kita,et al. Localization of eosinophil‐derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes , 1998, Journal of leukocyte biology.
[67] K. Dyer,et al. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. , 1998, The Journal of infectious diseases.
[68] A. Fryer,et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.
[69] K. Dyer,et al. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes. , 1997, Genomics.
[70] E. Olson,et al. Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[71] K. Acharya,et al. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. , 1995, Structure.
[72] J F Vliegenthart,et al. New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. , 1994, Biochemistry.
[73] D. Newton,et al. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. , 1994, The Journal of biological chemistry.
[74] C. Oxvig,et al. Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein , 1994, FEBS letters.
[75] G. Gleich,et al. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. , 1993, The Journal of clinical investigation.
[76] D. Tenen,et al. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. , 1993, Journal of immunology.
[77] G. Gleich,et al. The biology of the eosinophilic leukocyte. , 1993, Annual review of medicine.
[78] H. Kita,et al. Eosinophil granule proteins in peripheral blood granulocytes , 1992, Journal of leukocyte biology.
[79] A. Fryer,et al. Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. , 1992, The Journal of clinical investigation.
[80] D. Loegering,et al. Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. , 1992, The Journal of biological chemistry.
[81] A. Dvorak,et al. Charcot‐Leyden crystal protein in the degranulation and recovery of activated basophils , 1992, Journal of leukocyte biology.
[82] G. Gleich,et al. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.
[83] M. Heise,et al. Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. , 1990, Genomics.
[84] R. L. Barker,et al. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. , 1990, Journal of immunology.
[85] L. Patthy. Homology of cytotoxic protein of eosinophilic leukocytes with IgE receptor Fcϵ RII: Implications for its structure and function , 1989 .
[86] D. Tenen,et al. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity , 1989, The Journal of experimental medicine.
[87] D. Tenen,et al. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[88] R. L. Barker,et al. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. , 1987, The Journal of parasitology.
[89] D. Loegering,et al. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[90] H. Haugen,et al. Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. , 1986, Journal of immunology.
[91] J. Harley,et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. , 1983, Journal of immunology.
[92] T. Habermann,et al. Localization of eosinophil granule major basic protein in human basophils , 1983, The Journal of experimental medicine.
[93] R. Dahl,et al. The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. , 1982, The Journal of allergy and clinical immunology.
[94] W. Henderson,et al. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. , 1982, Journal of immunology.
[95] G. Gleich,et al. Formation of Charcot-Leyden crystals by human basophils , 1982, The Journal of experimental medicine.
[96] R. Locksley,et al. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. , 1982, The Journal of clinical investigation.
[97] A. Capron,et al. Activation of rat and human eosinophils by soluble factor(s) released by Schistosoma mansoni Schistosomula. , 1982, Cellular immunology.
[98] W. Henderson,et al. Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity. , 1980, Journal of immunology.